Mustang Bio Announces MB-106 CD20-Targeted CAR T Data Selected for Presentation at the 2022 Tandem Meetings I Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR
Stock Information for Fortress Biotech Inc.
Loading
Please wait while we load your information from QuoteMedia.